| # | Country | Total Patents | |
|---|---|---|---|
| #1 | United States | 9 | |
| #2 | EPO (European Patent Office) | 7 | |
| #3 | China | 6 | |
| #4 | Australia | 5 | |
| #5 | Republic of Korea | 4 | |
| #6 | WIPO (World Intellectual Property Organization) | 3 | |
| #7 | Canada | 2 | |
| #8 | Hong Kong | 2 | |
| #9 | Japan | 2 | |
| #10 | Mexico | 1 |
| # | Industry | |
|---|---|---|
| #1 | Pharmaceuticals | |
| #2 | Organic fine chemistry |
| # | Technology | |
|---|---|---|
| #1 | Medical preparations | |
| #2 | Therapeutic chemical compounds | |
| #3 | Heterocyclic compounds | |
| #4 | Acyclic or carbocyclic compounds |
| # | Name | Total Patents |
|---|---|---|
| #1 | Pershadsingh Harrihar A | 39 |
| #2 | Avery Mitchell A | 8 |
| #3 | Avery Mitchell Allen | 2 |
| #4 | Kurtz Theodore W | 1 |
| #5 | Pershadsingh Harrihar Ajodhya | 1 |
| Publication | Filing date | Title |
|---|---|---|
| WO2005009437A1 | Design and synthesis of optimized ligands for ppar | |
| US7232828B2 | PPAR Ligands that do not cause fluid retention, edema or congestive heart failure | |
| AU2002303156A1 | Design and synthesis of optimized ligands for ppar | |
| US6664287B2 | Antioxidants | |
| AU7995300A | Dithiolane derivatives |